Previous close | 125.87 |
Open | 125.03 |
Bid | 127.33 x 21400 |
Ask | 127.44 x 12000 |
Day's range | 124.19 - 127.60 |
52-week range | 61.95 - 127.60 |
Volume | |
Avg. volume | 377,530 |
Market cap | 13.308B |
Beta (5Y monthly) | 0.51 |
PE ratio (TTM) | 190.21 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.36 (0.29%) |
Ex-dividend date | 29 Feb 2024 |
1y target est | N/A |
Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced the launch of the groundbreaking Visage Ease VP for Apple Vision Pro, Apple's highly anticipated spatial computing platform released today.
Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will be showcasing a series of exciting new product additions and innovations, as well as the industry-leading Visage® 7 Enterprise Imaging Platform ("Visage 7"), engineered for CloudPACS (cloudpacs.com™) at the Radiological Society of North America (RSNA) 2023 annual meeting, Booth 4329, McCormick Place South Hall (Chicago, IL) from Sunday, November 26 – Wednesday, November 29, 2023.